Tests employed in the psychometric validation of the Insulin Treatment Appraisal Scale (ITAS) in T2DM patients; a systematic review of the literature
Open Access
- 25 October 2024
- journal article
- research article
- Published by Springer Nature in Journal of Patient-Reported Outcomes
- Vol. 8 (1) , 1-15
Abstract
Background: Psychological Insulin Resistance (PIR) and negative perceptions regarding insulin treatment are noteworthy challenges in T2DM management, which hinder the timely initiation of insulin treatment. To get past these obstacles a reliable tool is required to evaluate patients’ perspectives on insulin administration. Our study aims to conduct a comprehensive systematic review to evaluate the validity and reliability of different validation tests used in the psychometric validation of the ITAS in T2DM patients. Methods: A literature search was carried out, using PubMed, Google Scholar, EMBASE, Cochrane Library and Science Direct. Only those studies assessing content validity, construct validity, concurrent validity, discriminant validity, internal consistency reliability (Cronbach’ α), and items-total correlation were retrieved. Results: A total of 14 studies illustrated the validity and reliability of ITAS in T2DM patients. Content validity results of S-CVI was 0.97, and I-CVI was 0.8–1.00. Construct validity with factor loading was greater than the threshold value of 0.3. The concurrent validity of ITAS vs. PAID, WHO-5, and SPI was 0.35 (P < 0.05), −0.14 (P < 0.05), and 0.80 (P < 0.001) respectively. The mean difference between insulin and non-insulin group was significant (P < 0.001) showing reliable discriminant validity. Reported results of Cronbach’s α for the main scale (0.79–0.89), subscale-1 (0.72–0.9), and subscale-2 (0.61–0.89) showed “good to excellent” internal consistency reliability of ITAS. Item-total correlation results for the main scale, subscale-1, and subscale-2 were (0.40–0.82), (0.31–0.74) and (0.34–0.58) respectively. Test-retest reliability of ITAS was 0.571–0.87. Conclusions: Study findings confirm the robustness of various validation tests utilized in the psychometric validation of ITAS in T2DM patients. ITAS is a well-validated and reliable tool for determining the perspectives, PIR, and changes in patients’ perception over time and it can be used to overcome hurdles in the timely initiation of insulin treatment in T2DM patients.Keywords
This publication has 42 references indexed in Scilit:
- Validation of the Chinese version of the insulin treatment appraisal scaleDiabetes Research and Clinical Practice, 2020
- A Practitioner’s Toolkit for Insulin Motivation in Adults with Type 1 and Type 2 Diabetes Mellitus: Evidence-Based Recommendations from an International Expert PanelDiabetes Therapy, 2020
- Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th editionDiabetes Research and Clinical Practice, 2019
- COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi studyQuality of Life Research, 2018
- COSMIN guideline for systematic reviews of patient-reported outcome measuresQuality of Life Research, 2018
- COSMIN Risk of Bias checklist for systematic reviews of Patient-Reported Outcome MeasuresQuality of Life Research, 2017
- The Use of Cronbach’s Alpha When Developing and Reporting Research Instruments in Science EducationResearch in Science Education, 2017
- Barriers to Initiating Insulin in Type 2 Diabetes Patients: Development of a New Patient Education Tool to Address Myths, Misconceptions and Clinical RealitiesThe Patient - Patient-Centered Outcomes Research, 2014
- Evaluation of perception of insulin therapy among Chinese patients with type 2 diabetes mellitusDiabetes & Metabolism, 2011
- Focus on psychometrics. Aspects of item analysisResearch in Nursing & Health, 1991